| Request a sample from "The Infoshop", another service of Global Information.
|
SUMMARY
This research service covers the U.S. osteoporosis market from 2004-2014.
Included are disease overviews, technology trends, total market revenue
forecasts, market segment revenue forecasts, and market share analysis. The
market is segmented by product class: bisphosphonates, selective estrogen
receptor modulators, calcitonins, parathyroid hormones, and novel therapeutic
approaches. Major market challenges, drivers, and restraints and identified
and discussed.
TABLE OF CONTENTS
1. EXECUTIVE SUMMARY
Executive Summary
2. MARKET INTRODUCTION
Research Scope and Methodology
- Scope & Segmentation
- Research Methodology
Market Overview
- Market Engineering Measurements
- Disease Overview
- Treatment Options
- Patient Forecasts
- Industry Challenges
- Market Drivers
- Market Restraints
Product Analysis
- Bisphosphonates
- Selective Estrogen Receptor Modulators
- Calcitonins
- Parathyroid Hormones
Pipeline Analysis
- Bisphosphonates
- Selective Estrogen Receptor Modulators
- Calcitonins
- Parathyroid Hormones
- Novel Therapeutic Approaches
3. COMPETITIVE ANALYSIS
Competitive Analysis
Forecasts and Trends
- Total Market
- Bisphosphonates
- Selective Estrogen Receptor Modulators
- Calcitonins
- Parathyroid Hormones
- Novel Therapeutic Approaches
Market Share Analysis
- Company Market Share
- Product Market Share
4. APPENDIX
Decision Support Databases
- Male Population 65 Plus
- Female Population 65 Plus
- Percentage of Population 65 Plus
- Total Population 65 Plus
- U.S. Population with Osteoporosis
|
